Table 2.

Risk of Hematological Malignancies among Individuals with AUDs.

Disease	Men				Women				All
	O	SIR	95% CI		O	SIR	95% CI		O	SIR	95% CI
Non-Hodgkin lymphoma	791	0.64	0.60	0.69	150	0.69	0.58	0.81	941	0.65	0.61	0.69
Diffuse large B cell	107	0.83	0.68	1.01	24	0.98	0.62	1.45	131	0.86	0.72	1.02
Follicular	48	0.72	0.53	0.96	14	0.72	0.39	1.21	62	0.72	0.55	0.93
Hodgkin disease	184	0.70	0.60	0.81	41	0.77	0.55	1.04	225	0.71	0.62	0.81
Mixed cellularity classic	15	0.86	0.48	1.42	3	1.18	0.22	3.49	18	0.90	0.53	1.43
Nodular sclerosis classic	58	1.27	0.96	1.64	12	0.76	0.39	1.33	70	1.14	0.89	1.44
Myeloma	167	0.53	0.45	0.61	29	0.49	0.33	0.70	196	0.52	0.45	0.60
Leukemia	325	0.52	0.46	0.58	68	0.46	0.36	0.59	393	0.51	0.46	0.56
Acute lymphatic leukemia	55	0.49	0.37	0.63	17	0.57	0.33	0.91	72	0.50	0.39	0.63
Acute myeloid leukemia	54	0.31	0.24	0.41	9	0.21	0.09	0.39	63	0.29	0.22	0.37
Chronic myeloid leukemia	52	0.53	0.40	0.70	11	0.58	0.29	1.04	63	0.54	0.41	0.69
All	1467	0.60	0.57	0.63	288	0.60	0.54	0.68	1755	0.60	0.57	0.63

O, observed number of cases; SIR, standardized incidence ratio; CI, confidence interval.

Bold type, 95% CI does not include 1.00.